NAD/FTC referral
This article was originally published in The Rose Sheet
Executive Summary
National Advertising Division of the Council of Better Business Bureaus refers Planet Emu to the Federal Trade Commission for possible law enforcement action after firm disregards NAD's requests for substantiation related to claims for Deception Wrinkle-Cheating Cream, watchdog group reports Nov. 30. Among the claims in question, which appeared on firm's Web site and in direct marketing emails, are "instant wrinkle CURE endorsed by every major fashion and beauty magazine;" "much better than Botox;" and "makes wrinkles almost invisible to the naked eye"...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.